Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Job Description The Division of Medical Genetics has an outstanding opportunity for a highly skilled Research Scientist/Engineer 3(FULL-TIME) in the laboratory of Mary-Claire King PhD. Field
-
18 Mar 2026 Job Information Organisation/Company Universidade do Minho Research Field Technology » Biotechnology Researcher Profile Recognised Researcher (R2) Positions PhD Positions Application
-
, pharmacology, cell and molecular biology, imaging and nuclear medicine, ophthalmology, rehabilitation, tissue engineering, food animal, equine, and small animal medicine and surgery, and others. Research
-
gastric cancer tissue and malignant ascites using single-cell RNA sequencing and computational mapping to NK-cell reference atlases. Engineering TME-resilient NK cells through precise genetic editing of key
-
Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 30 Apr 2026 - 12:30 (Europe/Rome) Country Italy Type of Contract Not Applicable Job Status Not Applicable Offer
-
in include: 1. How do we engineer cells to turn genes on or off? 2. How do we explore numerous combinations of genetic perturbations in a scalable way? 3. How do we engineer immune recognition
-
techniques for biological tissue studies. The candidate will work is this research team. The PhD candidate will present his work in international conferences around the world (1 to 3 international trips
-
, please visit our website at https://www.cruk.cam.ac.uk/research-groups/gilbertson-group/ Project details The central nervous system (CNS) represents a uniquely regulated immune environment that changes
-
training. PhD: 3-4 years full-time; 5 years part-time; MD (Doctor of Medicine): 2 years full-time; 4 years part-time; MSc (Research): 1 year full-time; 2 years part-time; Apply now Research projects Research
-
for Inflammation Research (IRC) investigates the molecular and cellular mechanisms of inflammation, including inter- and intracellular signaling, immune cell biology, barrier tissue function, and the transition from